Skip to content

To assess the efficacy of Shadbindu oil in management of Unilateral headache.

A critical study on â?? Nasa hi shiraso dwaram ? and its applied anatomy with special reference to Ardhavabhedaka - NIL

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/07/055786
Enrollment
46
Registered
2023-07-27
Start date
Unknown
Completion date
Unknown
Last updated
2023-08-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G939- Disorder of brain, unspecified

Interventions

None listed

Sponsors

Dept of PanchakarmaFaculty of AyurvedaInstitute of Medical Science
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients with sign and symptoms of Ardhavabhedaka 2.Patients who are fit for Nasya karma according to Ayurveda text books. 3.Willing to complete daily diary 4.Willing to take the medication for 30 days

Exclusion criteria

Exclusion criteria: 1. Major medical illness under treatment 2. Pregnancy 3. High blood pressure/low blood pressure 4. Use of any other alternative medication during the study period 5. Patient not willing to give his/her consent 6. Patient suffering from secondary causes of headache

Design outcomes

Primary

MeasureTime frame
Relief in sign & symptoms of the disease. The main sign & symptoms in the study are as follows: Severity of Headache Frequency of Headache Duration of Headache Nausea VomitingTimepoint: 30 days study with follow-up at 15 days

Secondary

MeasureTime frame
eduction in scoring of following scales 1 Migraine Disability Assessment Score 2 Visual Analog Scale Timepoint: 30 days study with follow-up at 15 days

Countries

India

Contacts

Public ContactProf Kameshwar Nath Singh

Banaras hindu university

nishant.kumar886@gmail.com9473533848

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026